A heterozygous variant of FGF13 caused X-linked developmental and epileptic encephalopathy 90 in a Chinese family

Haiying Cheng,Pu Miao,Ye Wang,Yufan Guo,Liuyan Gao,Yuting Lou,Fan Yang,Mengmeng Liang,Jianhua Feng
DOI: https://doi.org/10.1159/000531932
2023-08-03
Cytogenetic and Genome Research
Abstract:Developmental and epileptic encephalopathy (DEE) refers to a group of severe epilepsy encephalopathy and development disorders, and its typical clinical features include seizures, drug resistance, and developmental delay or regression. To date, limited studies have reported DEEs driven by FGF13. Here, we reported a girl with DEE90 caused by variant of FGF13. Her electroencephalography (EEG) showed discontinuous hypsarrhythmia, and a heterozygous nonsynonymous variant in FGF13 [NM_004114.4: c.5C>G, p.(Ala2Gly)] was identified from the proband. The variant was not reported in public databases such as gnomAD and Exome Aggregation Consortium (ExAC), and predicted to be damaging to proteins and classified as likely pathogenic (LP) according to the ACMG guidelines. The seizure was finally controlled by a combination of ACTH + zonisamide (10 mg/kg.d) + levetiracetam (52 mg/kg.d) + clonazepam (0.7 mg/kg.d).
cell biology,genetics & heredity
What problem does this paper attempt to address?